patent/UA-80661-C2

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c0cf5140a29785f5c8fdd8a3338afa22
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-465 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
filingDate	2006-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb4e6958d3d65767567fc3a2841d5ffc
publicationDate	2007-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	UA-80661-C2
titleOfInvention	The pharmaceutical formulation for a skin affection treatment
abstract	The invention relates to a pharmaceutics and medicine, particularly, to dermatology and concerns a new pharmaceutical formulation for the treatment of skin affection. The formulation in a suspension form contains a flurenizide, dimexide, glycerine and water.
priorityDate	2006-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID679 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483452 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538066 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID753

Total number of triples: 19.